Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reducedejection fraction and type 2 diabetes

被引：0
|
作者：
El-Chouli, M. [1 ]
Barcella, C. A. [1 ]
Mohr, G. H. [2 ]
Mudalige, N. [3 ]
Folke, F. [4 ]
Torp-Pedersen, C. [5 ]
Bruun, N. E. [1 ]
Lindhardsen, J. [4 ]
Ahlehoff, O. [6 ]
Gislason, G. [4 ]
Skov, L. [4 ]
Eroglu, T. [4 ]
机构：
[1] Zealand Univ Hosp, Copenhagen, Denmark
[2] Glostrup Cty Hosp, Glostrup, Denmark
[3] Univ British Columbia, Hlth Syst Intelligence Unit, Data Analyt, Vancouver, BC, Canada
[4] Herlev & Gentofte Hosp, Copenhagen, Denmark
[5] Nordsjaellands Hosp, Hillerod, Denmark
[6] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes
    Alghamdi, M.
    Singh, J.
    Lang, C.
    Mordi, I
    Khan, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] Epicardial adipose tissue in patients with heart failure
    Doesch, Christina
    Haghi, Dariusch
    Fluechter, Stephan
    Suselbeck, Tim
    Schoenberg, Stefan O.
    Michaely, Henrik
    Borggrefe, Martin
    Papavassiliu, Theano
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2010, 12
  • [3] Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus
    Shi, Yu-Jiao
    Dong, Guo-Ju
    Guo, Ming
    WORLD JOURNAL OF DIABETES, 2023, 14 (06) : 724 - 740
  • [4] Epicardial adipose tissue in patients with heart failure
    Christina Doesch
    Dariusch Haghi
    Stephan Flüchter
    Tim Suselbeck
    Stefan O Schoenberg
    Henrik Michaely
    Martin Borggrefe
    Theano Papavassiliu
    Journal of Cardiovascular Magnetic Resonance, 12
  • [5] The Effect of Metformin and Dapagliflozin on Epicardial Adipose Tissue in Prediabetes and Type 2 Diabetic Patients
    Al-Talabany, Shaween
    Weir-McCall, Jonathan
    Mohan, Mohapradeep
    Singh, Jagdeep S.
    Mordi, Ify
    Gandy, Stephen J.
    Khan, Faisel
    Choy, Annamaria
    Houston, John G.
    Pearson, Ewan
    George, Jacob
    Struthers, Allan D.
    Lang, Chim C.
    DIABETES, 2018, 67
  • [6] Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure
    Wang, Dennis D.
    Naumova, Anna V.
    Isquith, Daniel
    Sapp, Jamie
    Huynh, Kim A.
    Tucker, Isabella
    Balu, Niranjan
    Voronyuk, Anna
    Chu, Baocheng
    Ordovas, Karen
    Maynard, Charles
    Tian, Rong
    Zhao, Xue-Qiao
    Kim, Francis
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [7] Impact of Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction
    Koepp, Katlyn E.
    Obokata, Masaru
    Reddy, Yogesh N.
    Olson, Thomas P.
    Borlaug, Barry A.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S4 - S4
  • [8] Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
    Dhore-Patil, Aneesh
    Urina-Jassir, Daniela
    Samson, Rohan
    Le Jemtel, Thierry H.
    Oparil, Suzanne
    CURRENT HYPERTENSION REPORTS, 2024, 26 (09) : 381 - 388
  • [9] Proteomics of epicardial adipose tissue in patients with heart failure
    Zhao, Lei
    Guo, Zongsheng
    Wang, Pan
    Zheng, Meili
    Yang, Xiaoyan
    Liu, Ye
    Ma, Zheng
    Chen, Mulei
    Yang, Xinchun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (01) : 511 - 520
  • [10] EPICARDIAL ADIPOSE TISSUE VOLUME AND CHARACTERISTICS ARE ASSOCIATED WITH STAGE B HEART FAILURE IN TYPE 2 DIABETES
    Ayton, Sarah L.
    Yeo, Jian L.
    Gulsin, Gaurav S.
    Dattani, Abhishek
    Brady, Emer M.
    Arnold, J. Ranjit
    Graham-Brown, Matthew P. M.
    Singh, Anvesha
    Dey, Damini
    McCann, Gerry P.
    Moss, Alastair J.
    HEART, 2022, 108 : A4 - A4
12345